Alvotech

Reykjavík, Capital Region, Iceland

+354 422 4500 ★

http://www.alvotech.com

Company profile

Alvotech company profile

Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments. Alvotech was established on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.

Business identity

Website: http://www.alvotech.com
Contact email: [email protected]
Phone number: +354 422 4500
Operating status: Active
Company type: For Profit
Employee range: 01001-05000 employees
Revenue range: $100K+
Founded: 2013-01-01

LinkedIn Facebook X

Headquarters

Headquarters: Reykjavík, Capital Region, Iceland
Postal code: 101
Country code: IS
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Ipo
Funding rounds: 12
Total equity funding: $398.5M
Last funding: Post Ipo Debt / $100M / 2025-12-31
Last equity funding: Post Ipo Equity / $33.2M
Investors: 7
Lead investors: 3
Founders: 1
Articles: 542
Exited on: 2022-06-16

Categories and groups

Biotechnology Life Science Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Róbert Wessman

Lead investors

AlvogenFuji PharmaGoldenTree Asset Management

Investors

AlvogenAthos CapitalBaxter VenturesGoldenTree Asset ManagementShinhan Capital

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.